Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 CD45+CD3CD56+CD16+ pNK cells and CD56+ uNK cells in RM patients

From: The impact of previous live births on peripheral and uterine natural killer cells in patients with recurrent miscarriage

   RM (n = 575) pRM (n = 393) sRM (n = 182) p-value
CD45+CD3CD56+CD16+
pNK cells
Percentages (mean ± SD) 12.0 ± 5.3 12.4 ± 5.5 11.1 ± 4.6 0.0043
Absolute numbers (mean ± SD) 228.3 ± 116.4 239.1 ± 118.7 205.1 ± 107.9 0.0011
CD56+ uNK cells Absolute numbers (mean ± SD) 215.2 ± 180.3 (n = 346)a 205.4 ± 170.2 (n = 245)a 238.8 ± 201.6 (n = 101)a 0.12
   iRM (n = 248) ipRM (n = 167) isRM (n = 81) p-value
CD45+CD3CD56+CD16+
pNK cells
Percentages (mean ± SD 12.2 ± 5.1 12.8 ± 5.4 11.1 ± 4.3 0.0181
Absolute numbers (mean ± SD) 232.2 ± 111.9 244.9 ± 112.9 206.0 ± 105.6 0.0099
CD56+ uNK cells Absolute numbers (mean ± SD) 242.5 ± 207.1 (n = 156)a 218.2 ± 184.5 (n = 102)a 288.4 ± 239.3 (n = 54)a 0.044
  1. RM = recurrent miscarriage, pRM = primary RM, sRM = secondary RM, iRM = idiopathic RM, ipRM = idiopathic primary RM, isRM = idiopathic secondary RM.
  2. aindicates the number of patients in which a uterine biopsy was obtained